You are here: Industry Insights > merger

News List

Arsanis and X4 Pharmaceuticals Announce Merger americanpharmaceuticalreview
November 28, 2018
Arsanis and privately-held X4 Pharmaceuticals have entered into a definitive merger agreement under which X4 Pharmaceuticals is expected to merge with a wholly-owned subsidiary .....
Edge Therapeutics & PDS Biotechnology to Merge contractpharma
November 27, 2018
Expected to create a combined company with a growing pipeline of next generation cancer immunotherapies
Takeda eyes up Shire pharmatimes
July 19, 2018
Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas.
Fresenius pulls out of $4.3bn Akorn merger pharmatimes
July 16, 2018
German healthcare firm Fresenius Kabi is walking away from a $4.3-billion merger with US generics group Akorn, claiming that the latter has failed to fulfill several closing conditions.
Versartis, Aravive enter into merger agreement biospectrumasia
June 05, 2018
The transaction will result in a clinical stage, Nadsaq-listed company, based in Houston, Texas, focused on the development of innovative oncology therapeutics.
Proterris and Alfama complete merger to create carbon monoxide therapy leader pharmaceutical-technology
May 09, 2017
Proterris has announced the completion of its merger with Alfama, creating a dominant player in carbon monoxide (CO) therapies.
PLx Pharma and Dipexium Pharmaceuticals Complete Merger americanpharmaceuticalreview
April 24, 2017
PLx Pharma Inc. completed its previously announced merger with Dipexium Pharmaceuticals, Inc. effective April 19, 2017. The combined company, PLx Pharma Inc., will begin trading on the NASDAQ Capital Market under the symbol “PLXP” on April 20, 2017.
Alpine Immune Sciences boosts prospects with Nivalis merger pharmafile
April 21, 2017
Alpine Immune Sciences has agreed a deal to merge with Nivalis Therapeutics, in an all-stock deal. The merger...
Sun Pharma: Sun Pharma resets goals, to focus on quality firstwordpharma
February 27, 2017
Dilip Shanghvi, managing director of Sun Pharmaceuticals, which has faced recent scrutiny from the FDA over issues at its plants, said he is trying to streamline quality-control processes that were overtaken by the merger with Ranbaxy, reported The Econom
Mast Therapeutics And Savara Sign Merger Agreement firstwordpharma
January 09, 2017
Proposed Merger Creates Specialty Pharmaceutical Company with Three Clinical-Stage Inhaled Product Candidates for Serious and Life-Threatening Diseases

Previous page 1 2 3 4 Next page